Pendal Group LTD Adaptive Biotechnologies Corp Transaction History

Pendal Group LTD

  • $12.2 Billion
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021
SELL
$37.26 - $67.74 $282,281 - $513,198
-7,576 Closed
0 $0
Q4 2020

Jan 21, 2021
BUY
$45.01 - $65.47 $675 - $982
15 Added 0.2%
7,576 $448,000
Q3 2020

Nov 02, 2020
BUY
$35.79 - $48.81 $270,608 - $369,052
7,561 New
7,561 $368,000
Q3 2019

Nov 12, 2019
SELL
$30.31 - $53.51 $3,455 - $6,100
-114 Closed
0 $0
Q2 2019

Aug 01, 2019
BUY
$40.3 - $48.3 $4,594 - $5,506
114 New
114 $0

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Pendal Group LTD Portfolio

Follow Pendal Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email